Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Phillips

Showing results (211-220 of 286) with videos related to

Pageof 29
Sort By:
IJTLD Open|January 13, 2025
Person-centred language for describing stratified approaches to TB treatmentM Nash, A Deluca, E Lessem, et al.
Nature Medicine|November 16, 2018
Publisher Correction: A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosisMarjorie Z Imperial, Payam Nahid, Patrick P J Phillips, et al.
Optics Express|October 6, 2012
High-energy, ceramic-disk Yb:LuAG laser amplifierM Siebold, M Loeser, F Roeser, et al.
Nature Medicine|November 7, 2018
A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosisMarjorie Z Imperial, Payam Nahid, Patrick P J Phillips, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 23, 2022
Factors associated with screening failure and study withdrawal in multidrug-resistant TBA Schwalb, R Cachay, A Wright, et al.
The Journal of Infectious Diseases|March 27, 2012
Innovative trial designs are practical solutions for improving the treatment of tuberculosisPatrick P J Phillips, Stephen H Gillespie, Martin Boeree, et al.
Bulletin of the World Health Organization|January 7, 2014
Principles for designing future regimens for multidrug-resistant tuberculosisGrania Brigden, Bern-Thomas Nyang'wa, Philipp du Cros, et al.
BMC Medicine|March 24, 2016
A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP)Patrick P J Phillips, Kelly E Dooley, Stephen H Gillespie, et al.
Journal of Clinical Microbiology|September 9, 2011
Molecular bacterial load assay, a culture-free biomarker for rapid and accurate quantification of sputum Mycobacterium tuberculosis bacillary load during treatmentIsobella Honeyborne, Timothy D McHugh, Patrick P J Phillips, et al.
Physical Review Letters|November 13, 2007
Benchmarking of electro-optic monitors for femtosecond electron bunchesG Berden, W A Gillespie, S P Jamison, et al.
Pageof 29

Showing results (211-220 of 286) with videos related to

Sort By:
Pageof 29
IJTLD Open|January 13, 2025
Person-centred language for describing stratified approaches to TB treatmentM Nash, A Deluca, E Lessem, et al.
Nature Medicine|November 16, 2018
Publisher Correction: A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosisMarjorie Z Imperial, Payam Nahid, Patrick P J Phillips, et al.
Optics Express|October 6, 2012
High-energy, ceramic-disk Yb:LuAG laser amplifierM Siebold, M Loeser, F Roeser, et al.
Nature Medicine|November 7, 2018
A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosisMarjorie Z Imperial, Payam Nahid, Patrick P J Phillips, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 23, 2022
Factors associated with screening failure and study withdrawal in multidrug-resistant TBA Schwalb, R Cachay, A Wright, et al.
The Journal of Infectious Diseases|March 27, 2012
Innovative trial designs are practical solutions for improving the treatment of tuberculosisPatrick P J Phillips, Stephen H Gillespie, Martin Boeree, et al.
Bulletin of the World Health Organization|January 7, 2014
Principles for designing future regimens for multidrug-resistant tuberculosisGrania Brigden, Bern-Thomas Nyang'wa, Philipp du Cros, et al.
BMC Medicine|March 24, 2016
A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP)Patrick P J Phillips, Kelly E Dooley, Stephen H Gillespie, et al.
Journal of Clinical Microbiology|September 9, 2011
Molecular bacterial load assay, a culture-free biomarker for rapid and accurate quantification of sputum Mycobacterium tuberculosis bacillary load during treatmentIsobella Honeyborne, Timothy D McHugh, Patrick P J Phillips, et al.
Physical Review Letters|November 13, 2007
Benchmarking of electro-optic monitors for femtosecond electron bunchesG Berden, W A Gillespie, S P Jamison, et al.
Pageof 29